This chapter highlights the need to intensify efforts to address health and safety issues in the advancement of carbon nanotechnology and in the nanotoxicology of manufactured carbon nanomaterials in the field of agriculture. An assessment is being done to produce data for safety evaluations, toxicological assessments of potential effects on human health, and risk assessments to assist risk management decisions, and policies are being developed to safeguard both human health and the environment. The regulatory impact on innovation in a developing industry is a last factor to be considered when regulating the dangers associated with nanomaterials. Nanotechnology breakthroughs are frequently created by little-known firms and start-ups, just like those in other emerging technological fields. These organisations lack the means and experience to evaluate the health and ecological hazards of nanoparticles in a reliable manner. In the short term, regulatory assessments will need to be taken because there are no explicit quantitative risk evaluations. As the application of nanomaterials expands, regulators will encounter a variety of choice situations when addressing the regulation of possible environmental contaminants. Agencies oversee, among other things, evaluating the magnitude of a regulatory problem, looking into and managing potential dangers, and giving instructions for the secure creation, use, and disposal of materials or technologies. Regulators must make decisions in each of these situations and deal with data issues that are made more difficult by the shortcomings of the current risk assessment systems. Regulators ought to investigate employing possible approaches to support short-term decision-making until the science of nanomaterial risk assessment advances in their entirety.